Your browser doesn't support javascript.
loading
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz, Carmen; Mateo, Francesca; Baiges, Alexandra; Ruiz de Garibay, Gorka; Junza, Alexandra; Johnson, Simon R; Miller, Suzanne; García, Nadia; Capellades, Jordi; Gómez, Antonio; Vidal, August; Palomero, Luis; Espín, Roderic; Extremera, Ana I; Blommaert, Eline; Revilla-López, Eva; Saez, Berta; Gómez-Ollés, Susana; Ancochea, Julio; Valenzuela, Claudia; Alonso, Tamara; Ussetti, Piedad; Laporta, Rosalía; Xaubet, Antoni; Rodríguez-Portal, José A; Montes-Worboys, Ana; Machahua, Carlos; Bordas, Jaume; Menendez, Javier A; Cruzado, Josep M; Guiteras, Roser; Bontoux, Christophe; La Motta, Concettina; Noguera-Castells, Aleix; Mancino, Mario; Lastra, Enrique; Rigo-Bonnin, Raúl; Perales, Jose C; Viñals, Francesc; Lahiguera, Alvaro; Zhang, Xiaohu; Cuadras, Daniel; van Moorsel, Coline H M; van der Vis, Joanne J; Quanjel, Marian J R; Filippakis, Harilaos; Hakem, Razq; Gorrini, Chiara; Ferrer, Marc; Ugun-Klusek, Aslihan.
Afiliación
  • Herranz C; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Mateo F; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Baiges A; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Ruiz de Garibay G; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Junza A; Department of Electronic Engineering, Institute of Health Research Pere Virgili (IIPSV), University Rovira i Virgili, Tarragona, Spain.
  • Johnson SR; Biomedical Research Network Centre in Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • Miller S; National Centre for Lymphangioleiomyomatosis, Nottingham University Hospitals NHS Trust, Nottinghamshire, Division of Respiratory Medicine, University of Nottingham, Nottingham, UK.
  • García N; National Centre for Lymphangioleiomyomatosis, Nottingham University Hospitals NHS Trust, Nottinghamshire, Division of Respiratory Medicine, University of Nottingham, Nottingham, UK.
  • Capellades J; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Gómez A; Department of Electronic Engineering, Institute of Health Research Pere Virgili (IIPSV), University Rovira i Virgili, Tarragona, Spain.
  • Vidal A; Biomedical Research Network Centre in Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • Palomero L; Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Espín R; Department of Pathology, University Hospital of Bellvitge, Oncobell, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Extremera AI; CIBER on Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Blommaert E; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Revilla-López E; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Saez B; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Gómez-Ollés S; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Ancochea J; Lung Transplant Unit, Pneumology Service, Lymphangioleiomyomatosis Clinic, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Valenzuela C; Lung Transplant Unit, Pneumology Service, Lymphangioleiomyomatosis Clinic, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Alonso T; Lung Transplant Unit, Pneumology Service, Lymphangioleiomyomatosis Clinic, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Ussetti P; Pneumology Service, La Princesa Research Institute, University Hospital La Princesa, Madrid, Spain.
  • Laporta R; Pneumology Service, La Princesa Research Institute, University Hospital La Princesa, Madrid, Spain.
  • Xaubet A; Pneumology Service, La Princesa Research Institute, University Hospital La Princesa, Madrid, Spain.
  • Rodríguez-Portal JA; Pneumology Service, University Hospital Clínica Puerta del Hierro, Majadahonda, Madrid, Spain.
  • Montes-Worboys A; Pneumology Service, University Hospital Clínica Puerta del Hierro, Majadahonda, Madrid, Spain.
  • Machahua C; Pneumology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Bordas J; Medical-Surgical Unit of Respiratory Diseases, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío, Seville, Spain.
  • Menendez JA; Biomedical Research Network Centre in Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Cruzado JM; Biomedical Research Network Centre in Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Guiteras R; Interstitial Lung Disease Unit, Department of Respiratory Medicine, University Hospital of Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Bontoux C; Biomedical Research Network Centre in Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • La Motta C; Interstitial Lung Disease Unit, Department of Respiratory Medicine, University Hospital of Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Noguera-Castells A; Biomedical Research Network Centre in Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Mancino M; Interstitial Lung Disease Unit, Department of Respiratory Medicine, University Hospital of Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Lastra E; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Rigo-Bonnin R; Experimental Nephrology, Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
  • Perales JC; Department of Nephrology, University Hospital of Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Viñals F; Experimental Nephrology, Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
  • Lahiguera A; Department of Nephrology, University Hospital of Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Zhang X; Department of Pathology, University Hospital Pitié-Salpêtrière, Faculty of Medicine, University of Sorbonne, Paris, France.
  • Cuadras D; Department of Pharmacy, University of Pisa, Pisa, Italy.
  • van Moorsel CHM; Biomedical Research Institute "August Pi i Sunyer" (IDIBAPS), Department of Medicine, University of Barcelona, Barcelona, Spain.
  • van der Vis JJ; Biomedical Research Institute "August Pi i Sunyer" (IDIBAPS), Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Quanjel MJR; Genetic Counseling Unit, Department of Medical Oncology, University Hospital of Burgos, Burgos, Spain.
  • Filippakis H; Clinical Laboratory, University Hospital of Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Hakem R; Department of Physiological Science II, University of Barcelona, Barcelona, Spain.
  • Gorrini C; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Ferrer M; Department of Physiological Science II, University of Barcelona, Barcelona, Spain.
  • Ugun-Klusek A; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
EMBO Mol Med ; 13(9): e13929, 2021 09 07.
Article en En | MEDLINE | ID: mdl-34378323
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfangioleiomiomatosis / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfangioleiomiomatosis / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: España